OR WAIT null SECS
July 03, 2022
Lack of toxicity data and poor physicochemical properties must be overcome.
June 03, 2022
The right processes used with the right excipient combinations address evolving formulation needs.
May 26, 2022
Lubrizol has launched Apisolex technology to improve solubility and simplify the manufacturing of parenteral drug products.
March 18, 2022
New report released by USP offers a look into API supply-chain vulnerabilities.
February 17, 2022
ImmunoGen and Eli Lilly and Company have entered into an agreement that gives Lilly exclusive rights to research, develop, and commercialize ADCs designed for targets selected by Lilly from ImmunoGen’s camptothecin technology.
February 11, 2022
Piramal Pharma Solutions plans to construct a multipurpose ADC manufacturing and aseptic fill/finish facility in Grangemouth, Scotland, and to upgrades its existing API manufacturing facility in Morpeth, England.
February 03, 2022
In this episode of Drug Digest, Chris Spivey, editorial director, and Meg Rivers, senior editor, dive into APIs, excipients, and formulation advances, specifically pairing the right APIs and excipients for optimizing formulations.
January 18, 2022
In this episode of the Drug Solutions podcast, Chris Spivey, editorial director, and Meg Rivers, senior editor, interview experts on up-and-coming 2022 trends in the bio/pharma industry.
December 03, 2021
Increased patient-centricity and alternative dosage forms require careful consideration when selecting the best taste-masking approach.
Polymeric amorphous solid dispersions are the most commonly used technology, but amorphous APIs remain inherently unstable.